1004-03-1

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

29 Suppliers, 15 USDMF, 4 CEP/COS, 2 JDMF, 16 NDC API, 13 Listed Suppliers

DEVELOPMENTS

92 Drug(s) in Development

92 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

150 Dossiers, 66 FDA Orange Book, 27 Europe, 6 Canada, 27 Australia, 11 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;TOPICAL - 2%, SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.5%, CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

Suppliers, 10 BASF, 9 Seppic, 7 Kerry, 7 Nanjing Well Pharmaceutical, 6 Gangwal Chemicals, 5 Actylis, 4 Roquette, 3 Microlex e.U, 2 Corel Pharma Chem, 2 Lubrizol Life Science Health, 2 Nanjing Bold Chemical, 2 Finar, 1 Jai Radhe Sales, 1 Clariant, 1 DKSH, 1 BioSpectra, 1 SPI Pharma, 1 Gangwal Healthcare

EXCIPIENTS BY APPLICATIONS

23 Topical, 19 Solubilizers, 13 Parenteral, 9 Coating Systems & Additives, 9 Film Formers & Plasticizers, 8 Emulsifying Agents, 7 Thickeners and Stabilizers, 7 Co-Processed Excipients, 6 Surfactant & Foaming Agents, 4 Fillers, Diluents & Binders, 4 Direct Compression, 4 Lubricants & Glidants, 3 Controlled & Modified Release, 2 Granulation, 2 Rheology Modifiers, 1 API Stability Enhancers

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 31 Finished Drug Prices

MARKET PLACE

13 APIs, 15 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 6 EDQM Standards, 5 USP Standards, 6 Other Ref. Standards

DIGITAL CONTENT

37 News

37 News

Annual Sales of 1004-03-1 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

1004-03-1

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

29 Suppliers

15 USDMF

4 CEP/COS

2 JDMF

16 NDC API

13 Listed Suppliers

DEVELOPMENTS

92 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

150 Dossiers

66 FDA Orange Book

27 Europe

6 Canada

27 Australia

11 South Africa

13 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;TOPICAL - 2%

SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.5%

CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

Suppliers

10 BASF

9 Seppic

7 Kerry

7 Nanjing Well Pharmaceutical

6 Gangwal Chemicals

5 Actylis

4 Roquette

3 Microlex e.U

2 Corel Pharma Chem

2 Lubrizol Life Science Health

2 Nanjing Bold Chemical

2 Finar

1 Jai Radhe Sales

1 Clariant

1 DKSH

1 BioSpectra

1 SPI Pharma

1 Gangwal Healthcare

EXCIPIENTS BY APPLICATIONS

23 Topical

19 Solubilizers

13 Parenteral

9 Coating Systems & Additives

9 Film Formers & Plasticizers

8 Emulsifying Agents

7 Thickeners and Stabilizers

7 Co-Processed Excipients

6 Surfactant & Foaming Agents

4 Fillers, Diluents & Binders

4 Direct Compression

4 Lubricants & Glidants

3 Controlled & Modified Release

2 Granulation

2 Rheology Modifiers

1 API Stability Enhancers

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions

31 Finished Drug Prices

MARKET PLACE

13 APIs

15 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods

6 EDQM Standards

SOLUTION;TOPICAL - 5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons